hCG,Beta Subunit, Qnt

The beta-hCG test measures a hormone made mainly by the placenta during pregnancy. In early pregnancy, the level normally doubles every two to three days, and doctors use serial measurements to check if a pregnancy is developing normally. Very high levels or levels that do not fall after pregnancy can sometimes signal certain medical conditions that require further evaluation. In people who are not pregnant, this hormone should be at very low or undetectable levels, and any elevation may prompt additional testing. Your doctor will interpret your result alongside your symptoms, ultrasound findings, and other clinical information.

When elevated: Elevated β-hCG above expected gestational norms or in non-pregnant individuals may indicate gestational trophoblastic disease, multiple gestation, germ cell tumors, or rarely non-trophoblastic malignancies; very high or persistently rising levels post-delivery warrant urgent evaluation. When low: Levels lower than expected for gestational age or a suboptimal rate of rise in early pregnancy may suggest ectopic pregnancy, threatened or inevitable miscarriage, or fetal demise; in tumor surveillance, declining levels generally indicate treatment response.

β-hCG is not directly relevant to athletic performance, training, or recovery in non-pregnant athletes. For female athletes of childbearing age, a quantitative β-hCG test is primarily a pregnancy detection and monitoring tool; elevated levels outside pregnancy may warrant evaluation for rare tumor-related production, which would be a medical rather than performance concern.